360 High-Risk Vulnerability Immunization Tool V2.0 vs Kaseya Anti-Virus and Anti-Malware: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Kaseya Anti-Virus and Anti-Malware: Centralized AV/AM management and deployment platform within Kaseya VSA RMM. built by Kaseya. Core capabilities include Centralized antivirus and antimalware management within VSA, Network-wide policy deployment, Configurable dashboard for antivirus status monitoring..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Kaseya Anti-Virus and Anti-Malware differentiates with Centralized antivirus and antimalware management within VSA, Network-wide policy deployment, Configurable dashboard for antivirus status monitoring.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Kaseya Anti-Virus and Anti-Malware is developed by Kaseya. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Kaseya Anti-Virus and Anti-Malware serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Patch Management, Windows Security. Review the feature comparison above to determine which fits your requirements.